Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

North America Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type, By End Use, By Application, By Country and Growth Forecast, 2024 - 2031

Published Date : 14-Nov-2024

Pages: 113

Formats: PDF

The North America Biological Skin Substitutes Market would witness market growth of 8.1% CAGR during the forecast period (2024-2031).

The US market dominated the North America Biological Skin Substitutes Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $158,297 Thousands by 2031. The Canada market is experiencing a CAGR of 10.4% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 9.5% during (2024 - 2031).

North America Biological Skin Substitutes Market

Biological skin substitutes are advanced medical products designed to replace or mimic the function and structure of human skin, providing essential coverage and support for wounds, burns, and other skin injuries. These substitutes act as temporary or permanent coverings, promoting healing by creating an environment conducive to tissue regeneration and repair. Unlike traditional wound dressings, biological skin substitutes are engineered to integrate more effectively with human tissue, often incorporating layers that replicate the epidermis and dermis—the outer and inner layers of skin—to support natural healing processes.

Additionally, the biological skin substitutes market has emerged as a transformative segment within the broader wound care and tissue engineering industry, driven by advancements in biotechnology and the growing demand for effective wound management solutions. These substitutes' ability to promote healing, reduce infection risk, and enhance patient outcomes has sparked considerable interest in the medical and scientific communities, setting the stage for rapid market growth and innovation.

The region benefits from robust collaborations between government bodies, research institutions, and private companies, fostering innovation and streamlining product approvals. According to the Centers for Disease Control and Prevention (CDC), six out of ten U.S. adults are managing at least one chronic illness, with four out of ten dealing with multiple chronic conditions. The nation's healthcare expenses, which amount to approximately $4.1 trillion annually, are significantly influenced by these chronic diseases, which are among the most prevalent causes of disability. With chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores being common complications of these conditions, the demand for effective treatments, including biological skin substitutes, has increased significantly. These substitutes offer critical solutions in wound care, supporting tissue repair and reducing infection risks in patients with compromised healing capabilities.

Free Valuable Insights: The Biological Skin Substitutes Market is Predict to reach USD 568.3 Million by 2031, at a CAGR of 8.6%

Based on Type, the market is segmented into Human Donor Tissue-derived Products and Acellular Animal-derived Products. Based on End Use, the market is segmented into Hospitals, Outpatient Facilities, and Research & Manufacturing. Based on Application, the market is segmented into Acute Wounds and Chronic Wounds. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Smith & Nephew plc
  • Stryker Corporation
  • MIMEDX Group, Inc.
  • Organogenesis Holdings, Inc.
  • Integra LifeSciences Corporation
  • 3M Company
  • Essity AB (BSN Medical)
  • Zimmer Biomet Holdings, Inc.
  • Vericel Corporation
  • Molnlycke Health Care AB

North America Biological Skin Substitutes Market Report Segmentation

By Type

  • Human Donor Tissue-derived Products
  • Acellular Animal-derived Products

By End Use

  • Hospitals
  • Outpatient Facilities
  • Research & Manufacturing

By Application

  • Acute Wounds
  • Chronic Wounds

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biological Skin Substitutes Market, by Type
1.4.2 North America Biological Skin Substitutes Market, by End Use
1.4.3 North America Biological Skin Substitutes Market, by Application
1.4.4 North America Biological Skin Substitutes Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Porter Five Forces Analysis

Chapter 5. North America Biological Skin Substitutes Market by Type
5.1 North America Human Donor Tissue-derived Products Market by Region
5.2 North America Acellular Animal-derived Products Market by Region

Chapter 6. North America Biological Skin Substitutes Market by End Use
6.1 North America Hospitals Market by Country
6.2 North America Outpatient Facilities Market by Country
6.3 North America Research & Manufacturing Market by Country

Chapter 7. North America Biological Skin Substitutes Market by Application
7.1 North America Acute Wounds Market by Country
7.2 North America Chronic Wounds Market by Country

Chapter 8. North America Biological Skin Substitutes Market by Country
8.1 US Biological Skin Substitutes Market
8.1.1 US Biological Skin Substitutes Market by Type
8.1.2 US Biological Skin Substitutes Market by End Use
8.1.3 US Biological Skin Substitutes Market by Application
8.2 Canada Biological Skin Substitutes Market
8.2.1 Canada Biological Skin Substitutes Market by Type
8.2.2 Canada Biological Skin Substitutes Market by End Use
8.2.3 Canada Biological Skin Substitutes Market by Application
8.3 Mexico Biological Skin Substitutes Market
8.3.1 Mexico Biological Skin Substitutes Market by Type
8.3.2 Mexico Biological Skin Substitutes Market by End Use
8.3.3 Mexico Biological Skin Substitutes Market by Application
8.4 Rest of North America Biological Skin Substitutes Market
8.4.1 Rest of North America Biological Skin Substitutes Market by Type
8.4.2 Rest of North America Biological Skin Substitutes Market by End Use
8.4.3 Rest of North America Biological Skin Substitutes Market by Application

Chapter 9. Company Profiles
9.1 Smith & Nephew PLC
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional and Segmental Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Stryker Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 MiMedx Group. Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Research & Development Expenses
9.3.4 SWOT Analysis
9.4 Organogenesis Holdings, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expenses
9.5 Integra LifeSciences Holdings Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 3M Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Essity AB (BSN medical)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Zimmer Biomet Holdings, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 SWOT Analysis
9.10. Molnlycke Health Care AB
9.10.1 Company Overview
9.10.2 SWOT Analysis
TABLE 1 North America Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 2 North America Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 3 North America Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 4 North America Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 5 North America Human Donor Tissue-derived Products Market by Region, 2020 - 2023, USD Thousands
TABLE 6 North America Human Donor Tissue-derived Products Market by Region, 2024 - 2031, USD Thousands
TABLE 7 North America Acellular Animal-derived Products Market by Region, 2020 - 2023, USD Thousands
TABLE 8 North America Acellular Animal-derived Products Market by Region, 2024 - 2031, USD Thousands
TABLE 9 North America Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 10 North America Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 11 North America Hospitals Market by Country, 2020 - 2023, USD Thousands
TABLE 12 North America Hospitals Market by Country, 2024 - 2031, USD Thousands
TABLE 13 North America Outpatient Facilities Market by Country, 2020 - 2023, USD Thousands
TABLE 14 North America Outpatient Facilities Market by Country, 2024 - 2031, USD Thousands
TABLE 15 North America Research & Manufacturing Market by Country, 2020 - 2023, USD Thousands
TABLE 16 North America Research & Manufacturing Market by Country, 2024 - 2031, USD Thousands
TABLE 17 North America Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 18 North America Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 19 North America Acute Wounds Market by Country, 2020 - 2023, USD Thousands
TABLE 20 North America Acute Wounds Market by Country, 2024 - 2031, USD Thousands
TABLE 21 North America Chronic Wounds Market by Country, 2020 - 2023, USD Thousands
TABLE 22 North America Chronic Wounds Market by Country, 2024 - 2031, USD Thousands
TABLE 23 North America Biological Skin Substitutes Market by Country, 2020 - 2023, USD Thousands
TABLE 24 North America Biological Skin Substitutes Market by Country, 2024 - 2031, USD Thousands
TABLE 25 US Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 26 US Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 27 US Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 28 US Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 29 US Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 30 US Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 31 US Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 32 US Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 33 Canada Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 34 Canada Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 35 Canada Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 36 Canada Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 37 Canada Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 38 Canada Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 39 Canada Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 40 Canada Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 41 Mexico Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 42 Mexico Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 43 Mexico Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 44 Mexico Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 45 Mexico Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 46 Mexico Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 47 Mexico Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 48 Mexico Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 49 Rest of North America Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 50 Rest of North America Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 51 Rest of North America Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 52 Rest of North America Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 53 Rest of North America Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 54 Rest of North America Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 55 Rest of North America Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 56 Rest of North America Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 57 Key Information – Smith & Nephew PLC
TABLE 58 Key Information – Stryker Corporation
TABLE 59 Key Information – mimedx group inc
TABLE 60 Key Information – ORGANOGENESIS HOLDINGS, INC.
TABLE 61 Key Information – Integra Lifesciences Holdings Corporation
TABLE 62 Key Information – 3M Company
TABLE 63 Key Information – Essity AB
TABLE 64 Key Information – Zimmer Biomet Holdings, Inc.
TABLE 65 Key Information – Vericel Corporation
TABLE 66 Key Information – Molnlycke Health Care AB

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Biological Skin Substitutes Market, 2020 - 2031, USD Thousands
FIG 3 Key Factors Impacting Biological Skin Substitutes Market
FIG 4 Market Share Analysis, 2023
FIG 5 Porter’s Five Forces Analysis – Biological Skin Substitutes Market
FIG 6 North America Biological Skin Substitutes Market share by Type, 2023
FIG 7 North America Biological Skin Substitutes Market share by Type, 2031
FIG 8 North America Biological Skin Substitutes Market by Type, 2020 - 2031, USD Thousands
FIG 9 North America Biological Skin Substitutes Market share by End Use, 2023
FIG 10 North America Biological Skin Substitutes Market share by End Use, 2031
FIG 11 North America Biological Skin Substitutes Market by End Use, 2020 - 2031, USD Thousands
FIG 12 North America Biological Skin Substitutes Market share by Application, 2023
FIG 13 North America Biological Skin Substitutes Market share by Application, 2031
FIG 14 North America Biological Skin Substitutes Market by Application, 2020 - 2031, USD Thousands
FIG 15 North America Biological Skin Substitutes Market share by Country, 2023
FIG 16 North America Biological Skin Substitutes Market share by Country, 2031
FIG 17 North America Biological Skin Substitutes Market by Country, 2020 - 2031, USD Thousands
FIG 18 SWOT Analysis: Smith & Nephew PLC
FIG 19 SWOT Analysis: Stryker Corporation
FIG 20 Swot Analysis: MiMedx Group, Inc.
FIG 21 SWOT Analysis: Integra Lifesciences Holdings Corporation
FIG 22 SWOT Analysis: 3M Company
FIG 23 SWOT Analysis: Essity AB
FIG 24 SWOT Analysis: Zimmer Biomet Holdings, Inc.
FIG 25 Swot Analysis: Vericel Corporation
FIG 26 Swot Analysis: Molnlycke Health Care AB

Purchase Full Report of
North America Biological Skin Substitutes Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL